Affinity Asset Advisors, LLC Beyond Spring Inc. Transaction History

Affinity Asset Advisors, LLC

  • $690 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$9.37 - $12.12 $468,499 - $606,000
-50,000 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$10.61 - $15.77 $265,250 - $394,250
-25,000 Reduced 33.33%
50,000 $554,000
Q4 2020

Feb 12, 2021
BUY
$10.21 - $17.31 $765,750 - $1.3 Million
75,000 New
75,000 $915,000

Others Institutions Holding BYSI

# of Institutions
24
Shares Held
5.44M
Call Options Held
30.3K
Put Options Held
1.8K
View Full List

About BeyondSpring Inc.

BYSI Quotes by TradingView
  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $88.4M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email